News
AORT
20.57
+1.48%
0.30
Artivion Announces Release Date and Teleconference Call Details for First Quarter 2024 Financial Results
Artivion's first quarter 2024 financial results will be released on May 6, 2024 after the market closes. The Company will hold a teleconference call and live webcast at 4:30 p.m. ET to discuss the results. Artivion is a leading cardiac and vascular surgery company focused on aortic disease.
PR Newswire · 4d ago
Weekly Report: what happened at AORT last week (0415-0419)?
Weekly Report · 4d ago
Weekly Report: what happened at AORT last week (0408-0412)?
Weekly Report · 04/15 09:21
Needham sees BSX, CNMD, RMD beating Street, despite medtech slow down
Needham sees BSX, CNMD, RMD and Surmodics beating Street, despite medtech slow down. Needham estimates medtech sales grew less than expected in Q1, but that Boston Scientific, CONMED and ResMed should still beat the Street. The investment firm says medtech market only grew by 5.3% in the first quarter of 2024.
Seeking Alpha · 04/14 21:56
Artivion Is Maintained at Buy by Needham
Dow Jones · 04/08 18:44
Artivion Price Target Maintained With a $25.00/Share by Needham
Dow Jones · 04/08 18:44
Needham Maintains Buy on Artivion, Maintains $25 Price Target
Benzinga · 04/08 18:35
Artivion’s Growth Trajectory: A Buy Rating Amidst Promising Aortic Products and Financial Upswing
TipRanks · 04/08 18:15
Weekly Report: what happened at AORT last week (0401-0405)?
Weekly Report · 04/08 09:23
Analysts Forecast 10% Upside For The Holdings of IJT
NASDAQ · 04/03 11:23
Weekly Report: what happened at AORT last week (0325-0329)?
Weekly Report · 04/01 09:22
Artivion, Inc. (AORT) Hits Fresh High: Is There Still Room to Run?
NASDAQ · 03/29 13:15
Weekly Report: what happened at AORT last week (0318-0322)?
Weekly Report · 03/25 09:23
3 Buy-Rated Small Caps Flexing Big Growth
NASDAQ · 03/19 20:27
Weekly Report: what happened at AORT last week (0311-0315)?
Weekly Report · 03/18 09:23
Weekly Report: what happened at AORT last week (0304-0308)?
Weekly Report · 03/11 09:22
Artivion to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference
Artivion, Inc. Will participate virtually at the upcoming Oppenheimer 34th Annual Healthcare MedTech & Services Conference on March 13, 2023. The Company's virtual fireside chat is scheduled to begin at 10:40 a.m. ET. Artivion is a leading cardiac and vascular surgery company focused on aortic disease.
PR Newswire · 03/06 21:10
Weekly Report: what happened at AORT last week (0226-0301)?
Weekly Report · 03/04 09:23
Artivion files automatic mixed securities shelf
Seeking Alpha · 03/01 14:56
Analysts See 11% Gains Ahead For SPSM
NASDAQ · 03/01 12:03
More
Webull provides a variety of real-time AORT stock news. You can receive the latest news about Artivion, Inc. through multiple platforms. This information may help you make smarter investment decisions.
About AORT
Artivion, Inc. is a medical device company engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease, heart valve disease, aortic aneurysms, and dissections. The Company's segments include Medical Devices and Preservation Services. The Medical Devices segment includes sales of aortic stent grafts, surgical sealants, and On-X. The Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. It has four product families: aortic stent grafts, surgical sealants, On-X mechanical heart valves and related surgical products, and implantable cardiac and vascular human tissues. Aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Surgical sealants include BioGlue Surgical Adhesive products. It also sells or distributes PhotoFix bovine surgical patches.